Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667024 | SCV000791411 | likely pathogenic | Nemaline myopathy 2 | 2017-05-10 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostics Laboratory, |
RCV000667024 | SCV000890868 | pathogenic | Nemaline myopathy 2 | 2016-05-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000667024 | SCV004293396 | pathogenic | Nemaline myopathy 2 | 2023-12-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Met7828Serfs*51) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NEB-related conditions. ClinVar contains an entry for this variant (Variation ID: 551865). For these reasons, this variant has been classified as Pathogenic. |